The Cardiac Imaging Core (Core B) will provide service to all 3 projects with the goals of generating confocal microscopy- and in vivo ultrasound ? based analyses of cardiac development, structure, and function. Core B will be directed by Michael Rubart, M.D., who will provide expertise in confocal imaging of tissues. Dr. Rubart will be assisted by Ronald Payne, M.D., who will provide expertise in ultrasound imaging of embryonic and postnatal cardiac development and function. Core B's services enhance the efficiency of the Projects by providing consistent expertise in the capture and evaluation of images from tissue sections and hearts in vivo, using confocal microscopy and echocardiography, respectively. There are 2 Specific Aims for the Core:
Aim 1 will provide high-quality, unbiased confocal fluorescence imaging of the pre- and postnatal heart, as well as quantitative image analyses. Approaches utilized in Aim 1 will quantitatively assess (i) primitive streak formation and node polarity (Project 1), (ii) sarcomeric organization and cardiomyocyte polarity (Project 1-3), and (iii) ventricular wall trabeculation and compaction (Project 3). Imaging will be performed using a laser scanning confocal microscope equipped with multiple laser excitation lines and detector channels, as well as a variety of high/low magnification, high/low numerical aperture objectives.
Aim 2 will provide high-resolution in vivo ultrasound imaging of the pre- and postnatal heart in Projects 1-3 in order to generate quantitative data of structure, function, and flow relative to genetic alterations in cardiac development. In addition, ultrasound imaging will allow the study of longitudinal structural and functional data. Ultrasound imaging will utilize probes with frequency bands from 13 to 70 MHz, and linear array transducer technology, enabling imaging of hearts at different stages of development and frame acquisition at high rates, respectively. Available analysis software will enable quantification of cardiac contractile performance, chamber dimensions, and flow pattern, including detection and size estimation of intracardiac shunts. Overall, technologies utilized in the Cardiac Imaging Core will enable unbiased, quantitative assessments of changes in cardiac structure and function as a result of genetic alterations studied in each of the three Projects of this application.

Public Health Relevance

The proposed research is important because increasing evidence demonstrates that cardiomyopathies and congenital heart defects are a significant public burden; however, the mechanisms by which this occurs are poorly understood. Research in this area is crucial to both prevention and treatment, and therefore this research proposal addresses an important human health problem aligned with the mission of the NHLBI at the NIH.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL134599-03
Application #
9640227
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Program Officer
Schramm, Charlene A
Project Start
Project End
Budget Start
2019-02-01
Budget End
2020-01-31
Support Year
3
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Indiana University-Purdue University at Indianapolis
Department
Type
DUNS #
603007902
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Liu, Ying; Chen, Vincent H S; Shou, Weinian (2018) LUMA in cardiac development and function. Cardiovasc Res 114:347-348
Shi, Jianjian; Surma, Michelle; Wei, Lei (2018) Disruption of ROCK1 gene restores autophagic flux and mitigates doxorubicin-induced cardiotoxicity. Oncotarget 9:12995-13008
Miao, Lianjie; Li, Jingjing; Li, Jun et al. (2018) Notch signaling regulates Hey2 expression in a spatiotemporal dependent manner during cardiac morphogenesis and trabecular specification. Sci Rep 8:2678
Xiao, Deyong; Wang, Huijun; Hao, Lili et al. (2018) The roles of SMYD4 in epigenetic regulation of cardiac development in zebrafish. PLoS Genet 14:e1007578
Liu, Ying; Chen, Hanying; Shou, Weinian (2018) Potential Common Pathogenic Pathways for the Left Ventricular Noncompaction Cardiomyopathy (LVNC). Pediatr Cardiol 39:1099-1106
Xiao, Yun-Fei; Zeng, Zhi-Xiong; Guan, Xiao-Hui et al. (2018) FKBP12.6 protects heart from AngII-induced hypertrophy through inhibiting Ca2+ /calmodulin-mediated signalling pathways in vivo and in vitro. J Cell Mol Med 22:3638-3651
Wang, Jun; Shen, Tao; Zhu, Wuqiang et al. (2018) Protein phosphatase 5 and the tumor suppressor p53 down-regulate each other's activities in mice. J Biol Chem 293:18218-18229
Vincentz, Joshua W; Toolan, Kevin P; Zhang, Wenjun et al. (2017) Hand factor ablation causes defective left ventricular chamber development and compromised adult cardiac function. PLoS Genet 13:e1006922
Firulli, Beth A; Toolan, Kevin P; Harkin, Jade et al. (2017) The HAND1 frameshift A126FS mutation does not cause hypoplastic left heart syndrome in mice. Cardiovasc Res 113:1732-1742
Martinez, Hugo R; Ware, Stephanie M; Schamberger, Marcus S et al. (2017) Noncompaction cardiomyopathy and heterotaxy syndrome. Prog Pediatr Cardiol 46:23-27

Showing the most recent 10 out of 11 publications